Hikma Pharmaceuticals PLC Annual Report 2009

Since Hikma was founded, we have grown into a successful multinational pharmaceutical group. Our business today is diverse in its product line and the breadth of its geographic coverage. This diversification will ensure that we maintain our track record of strong growth

Chairman's statement

Hikma has once again delivered an outstanding performance. We have focused on integrity, high quality sales and cost management across all areas of our diversified business model, achieving record sales...

Read more of the Chairman's review

Chief Executive Officer’s review

2009 has been a very successful year for Hikma in which we have made excellent progress towards achieving our strategic objectives

Read more of the CEO's review

Group at a glance

We develop, manufacture and market generic and in‑licensed pharmaceutical products within three core businesses. Our operations span 49 countries and focus on key therapeutic areas such as...

Read more about the group
snippet-image-2

Delivering our strategy

In many markets in the MENA region, local manufacturing is critical to establishing a strong market presence. We are committed to developing our manufacturing capabilities in Algeria in order...

Read more about how we deliver our strategy
snippet-image-1